Bay98-7196, Dose Finding / POC Study

NCT02203331 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
319
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Bayer